Dr. Farren Isaacs is an Associate Professor of Molecular, Cellular, and Developmental Biology and Biomedical Engineering at Yale University. Dr. Isaacs has pioneered technologies for genome and RNA engineering for the construction of organisms with recoded genomes and production of novel chemicals, proteins, and materials to solve problems in biotechnology, materials science, environmental health, and medicine. Dr. Isaacs has been recognized with various awards, including a Beckman Young Investigator award by the Arnold and Mabel Beckman Foundation and a Young Professor award from DuPont, Inc. Innovations from his lab have led to the formation of biotechnology companies including enEvolv (acquired by Zymergen), 64x Bio, Peter Bio, and Pearl Bio. Dr. Isaacs received his B.S.E. in Bioengineering from the University of Pennsylvania, Ph.D. in Biomedical Engineering-Bioinformatics at Boston University, and conducted postdoctoral training in Genetics at Harvard Medical School.
